Want to join the conversation?
During 2Q16, $K's net sales rose by 8.6%, including pricing actions impact in Venezuela. Net sales, excluding impact of Venezuela fell by 2%. Operating profit rose by 10.6%, helped by savings from Project K & Zero-Based Budgeting in North America, as well as price increases in Venezuela. Excluding Venezuela impact, operating profit rose by 5.3%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?